Purchase Order 75D30118P02593

Award Date 8/31/18
Potential Completion Date 11/30/18
Potential Value $128K
Funding Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lansing, MI 48906, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC for WETVAX POTENCY TESTING. The contract has a potential value of $136,612.00 and is a Firm Fixed Price Purchase Order. The place of performance is Canton, MA 02021, USA. The contract does not have a set-aside designation. As the awardee, Emergent Biodefense Operations Lansing LLC is a for-profit...
<p>This is a contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Emergent Biodefense Operations Lansing LLC, also known as Emergent Biodefense, for the maintenance of a smallpox license. The contract is a delivery order with a firm fixed price of $38,430,000.00 and a completion date of January 31, 2019. The place of performance is located in Cambridge, Massachusetts. The contract does not have a set-aside designation.</p>
This federal contract award is for BAXTER CELL HARVEST services in year 6 of the contract, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense. The contract has a ceiling value of $38,250,000.00 and was awarded on September 30, 2016, with an ultimate completion date of August 31, 2018. It is a Firm Fixed Price delivery order contract. Emergent Biodefense is a for-profit manufacturer of...
<p>This is a $135,895.50 firm fixed price purchase order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC for the annual potency testing of the WETVAX (APSV) vials stored at the Strategic National Stockpile (SNS). The contract has an end date of August 31, 2022 and was awarded on May 12, 2022. No set-aside was used for this procurement.</p>
This is a $99,941,719.80 definitive, firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense, on March 16, 2017. The contract has an ultimate completion date of March 15, 2019 and is not set aside. Emergent Biodefense is a for-profit manufacturer of medical countermeasures and biopharmaceuticals, specializing in vaccines and therapeutics for public health...
This contract award, valued at $37,890,000, was issued by the Centers for Disease Control and Prevention (CDC) to Emergent BioDefense Operations Lansing LLC for the delivery of ACAM 2000 vaccines. ACAM 2000 is the only Food and Drug Administration (FDA)-licensed vaccine for the prevention of smallpox disease, a critical component of the U.S. government's strategic national stockpile. The contract, awarded on September 30, 2015, is a firm-fixed-price delivery order with an ultimate completion...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit manufacturer of medical countermeasures. The $1,174,464,339.10 firm fixed-price contract is for the production of BioThrax, the only FDA-licensed vaccine for the prevention of anthrax disease, which is a critical component of the U.S. government's strategic national stockpile. The...
The U.S. Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $41,801,810.00 firm fixed-price delivery order contract to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense, for the procurement of BioThrax (Anthrax Vaccine Adsorbed). This contract, which is not a set-aside, has an ultimate completion date of September 30, 2025. Emergent Biodefense is the prime contractor and manufacturer of BioThrax, the only...
This is a $19,763,563.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company and manufacturer of goods registered in the System for Award Management (SAM). The contract is part of the Centers for Innovation in Advanced...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price delivery order to Emergent, LLC, a for-profit limited liability company, under the Solutions for Enterprise Wide Procurement V (SEWP V) government-wide acquisition contract. The order has a potential value of $243,393.52 and is for the delivery of Red Hat Enterprise products and services. Emergent, LLC is a subsidiary of Mythics, LLC, another for-profit limited liability company that...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Purchase Order contract to Emergent Biodefense Operations Lansing LLC for vaccine potency testing services. The $127,526.00 contract has a completion date of November 30, 2018 and was awarded on August 31, 2018. The place of performance is Lansing, Michigan. Emergent Biodefense Operations Lansing LLC is a for-profit manufacturer. This contract was not set aside for any particular business type.

Generated 3/23/24, 7:43 PM